Orphazyme (Denmark) Price on October 10, 2024
| ORPHA Stock | DKK 939.90 10.10 1.06% |
If you're considering investing in Orphazyme Stock, it is important to understand the factors that can impact its price. As of today, the current price of Orphazyme stands at 939.90, as last reported on the 12th of December 2024, with the highest price reaching 939.90 and the lowest price hitting 892.10 during the day. Orphazyme appears to be very steady, given 3 months investment horizon. Orphazyme AS maintains Sharpe Ratio (i.e., Efficiency) of 0.0525, which implies the firm had a 0.0525% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Orphazyme AS, which you can use to evaluate the volatility of the company. Please evaluate Orphazyme's Risk Adjusted Performance of 0.0382, semi deviation of 3.73, and Coefficient Of Variation of 2427.31 to confirm if our risk estimates are consistent with your expectations.
Orphazyme Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Orphazyme |
Sharpe Ratio = 0.0525
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ORPHA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.63 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Orphazyme is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Orphazyme by adding it to a well-diversified portfolio.
Orphazyme Valuation on October 10, 2024
It is possible to determine the worth of Orphazyme on a given historical date. On October 10, 2024 Orphazyme was worth 1289.8 at the beginning of the trading date compared to the closed value of 1225.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Orphazyme stock. Still, in general, we apply an absolute valuation method to find Orphazyme's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Orphazyme where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Orphazyme's related companies.
| Open | High | Low | Close | Volume | |
| 1,280 | 1,300 | 1,200 | 1,207 | 152.00 | |
10/10/2024 | 1,290 | 1,290 | 1,205 | 1,225 | 12.00 |
| 1,235 | 1,284 | 1,201 | 1,219 | 29.00 |
| Backtest Orphazyme | | | Orphazyme History | | | Orphazyme Valuation | Previous | Next |
Orphazyme Trading Date Momentum on October 10, 2024
| On October 11 2024 Orphazyme AS was traded for 1,219 at the closing time. The highest price during the trading period was 1,284 and the lowest recorded bid was listed for 1,201 . The volume for the day was 29.0. This history from October 11, 2024 contributed to the next trading day price decline. The trading delta at closing time to the next closing price was 0.46% . The trading delta at closing time to the current price is 3.27% . |
Orphazyme AS Fundamentals Correlations and Trends
By evaluating Orphazyme's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Orphazyme's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Orphazyme financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Orphazyme Stock history
Orphazyme investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Orphazyme is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Orphazyme AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Orphazyme stock prices may prove useful in developing a viable investing in Orphazyme
Orphazyme AS, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark. Orphazyme is traded on Copenhagen Stock Exchange in Denmark.
Orphazyme Stock Technical Analysis
Orphazyme technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Orphazyme Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Orphazyme AS cannot be verified against its exchange. Please verify the symbol is currently traded on Copenhagen Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Orphazyme December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Orphazyme stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Orphazyme shares will generate the highest return on investment. By undertsting and applying Orphazyme stock market strength indicators, traders can identify Orphazyme AS entry and exit signals to maximize returns
Orphazyme Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Orphazyme's price direction in advance. Along with the technical and fundamental analysis of Orphazyme Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Orphazyme to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0382 | |||
| Jensen Alpha | 0.2394 | |||
| Total Risk Alpha | (0.56) | |||
| Sortino Ratio | 0.0159 | |||
| Treynor Ratio | (0.36) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Orphazyme Stock analysis
When running Orphazyme's price analysis, check to measure Orphazyme's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orphazyme is operating at the current time. Most of Orphazyme's value examination focuses on studying past and present price action to predict the probability of Orphazyme's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orphazyme's price. Additionally, you may evaluate how the addition of Orphazyme to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |